ClinicalTrials.Veeva

Menu

Protection Against Benzene Toxicity

National Institutes of Health (NIH) logo

National Institutes of Health (NIH)

Status

Completed

Conditions

Aplastic Anemia
Leukemia

Study type

Observational

Funder types

NIH

Identifiers

NCT00011453
9554-CP-001

Details and patient eligibility

About

We are investigating the role of an enzyme (NQO1) in protection against the bone marrow toxicity of the occupational and environmental toxicant benzene. All of the proposed studies involve use of human bone marrow cells in-vitro to define mechanisms of NQO1-mediated protection. Cells are obtained from healthy volunteers and protocols have undergone IRB review and approval.

Sex

All

Ages

21 to 65 years old

Volunteers

Accepts Healthy Volunteers

Inclusion and exclusion criteria

Healthy adult volunteers with blood counts in normal ranges and without evidence of hepatitis or HIV infection.

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems